MX9603797A - Agentes terapeuticos para su uso en la terapia del cancer. - Google Patents

Agentes terapeuticos para su uso en la terapia del cancer.

Info

Publication number
MX9603797A
MX9603797A MX9603797A MX9603797A MX9603797A MX 9603797 A MX9603797 A MX 9603797A MX 9603797 A MX9603797 A MX 9603797A MX 9603797 A MX9603797 A MX 9603797A MX 9603797 A MX9603797 A MX 9603797A
Authority
MX
Mexico
Prior art keywords
therapeutic agents
cancer therapy
formula
het
administering
Prior art date
Application number
MX9603797A
Other languages
English (en)
Other versions
MXPA96003797A (es
Inventor
Shama M Kajiji
Joseph P Lyssikatos
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9603797A publication Critical patent/MX9603797A/es
Publication of MXPA96003797A publication Critical patent/MXPA96003797A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Esta invencion se refiere aun método para el tratamiento del cáncer administrando un compuesto de la formula (Ver Formula); en la que A, X, G, Z, R3, R4, R5, R6, R7, R8, R9, R10, E1, E2 p, Het', het'' se definen como se indica en la descripcion. También se reivindican nuevos compuestos de la formula I.
MXPA/A/1996/003797A 1995-09-01 1996-08-30 Agentes terapeuticos para su uso en la terapia del cancer MXPA96003797A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US313695P 1995-09-01 1995-09-01
US003136 1995-09-01

Publications (2)

Publication Number Publication Date
MX9603797A true MX9603797A (es) 1997-07-31
MXPA96003797A MXPA96003797A (es) 1997-12-01

Family

ID=

Also Published As

Publication number Publication date
CA2184570A1 (en) 1997-03-02
EP0760239A3 (en) 1999-04-14
JPH09183725A (ja) 1997-07-15
EP0760239A2 (en) 1997-03-05

Similar Documents

Publication Publication Date Title
MY123354A (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
HK1023064A1 (en) Method of inhibiting bacterial or fungal growth using a complexing agent
GEP20032897B (en) Epothilone Derivatives
AP9701019A0 (en) Phenylamino-substituted tricycle derivatives.
AP9701041A0 (en) Pyridylpyrrole compounds.
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
MX9604020A (es) Arilalquildiazinonas.
HK1026691A1 (en) Substituted benzimidazoles and their use for treating retroviral infection
MY111201A (en) New imidazopyridines
PL307914A1 (en) Lipopetide derivatives, method of obtaining them and therapeutic agents containing such compounds
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
ZA937194B (en) 3,8-substituted deuteroporphyrin derivatives, pharmaceutical agents containing them and process for their production
NZ301645A (en) (R)-(-)-methyl phenyl oxazolidinone derivatives, pharmaceutical preparations and use for treating TNF stimulated diseases
MY119375A (en) Treatment of tinnitus using neuroprotective agents
MX9700429A (es) El uso de compuestos de tiazol y tiadiazol.
UA41355C2 (uk) Засіб для лікування нейро-сніду
AP9300561A0 (en) Antibiotic compounds.
PL313078A1 (en) Novel bis-naphtalimides for use in treating carcinoma
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
BG101220A (en) N-substituted 3-azabicyclo (93.2.0) heptane derivatives,their preparation and use
EP0774462A4 (en) HETEROCYCLIC COMPOUND
IL115184A (en) Use of anthracycline derivatives for preparing medivaments for treating amyloidosis
PT986393E (pt) Utilizacao de um nitroxido ou de um seu pro-farmaco no tratamento profilactico e terapeutico do cancro
NZ511559A (en) Use of staurosporine derivatives for treating ocular neovascular diseases
AU4706293A (en) Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine